Andrew Fordyce brings over 20 years of global sales and marketing strategies and strategic account management to his role on the Management Board of CP Kelco.

Fordyce’s previous responsibilities include Executive Vice President of Business Operations and Divisional Head for Novozymes, a global leader in biological solutions. His experience includes executive management in an organizational structure by both functional operations and business units, and a multifaceted career that has covered biotech innovation and business strategy, marketing and business portfolio management, and process engineering and application research.

Fordyce holds a Bachelor of Science in Chemical Engineering from the University of Colorado at Boulder and a PhD in Chemical Engineering from the University of Texas at Austin, as well as Executive Program certificates from Harvard Law School, Columbia Business School and INSEAD/Wharton.